356 related articles for article (PubMed ID: 22031047)
1. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant.
Chapman AK; Aucott SW; Milstone AM
J Perinatol; 2012 Jan; 32(1):4-9. PubMed ID: 22031047
[TBL] [Abstract][Full Text] [Related]
2. Skin Injuries and Chlorhexidine Gluconate-Based Antisepsis in Early Premature Infants: A Case Report and Review of the Literature.
Vanzi V; Pitaro R
J Perinat Neonatal Nurs; 2018; 32(4):341-350. PubMed ID: 29782437
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of 1% aqueous chlorhexidine gluconate compared with 10% povidone-iodine for topical antiseptic in neonates: effects on blood culture contamination rates.
Nuntnarumit P; Sangsuksawang N
Infect Control Hosp Epidemiol; 2013 Apr; 34(4):430-2. PubMed ID: 23466918
[TBL] [Abstract][Full Text] [Related]
4. Analyses comparing the antimicrobial activity and safety of current antiseptic agents: a review.
Hibbard JS
J Infus Nurs; 2005; 28(3):194-207. PubMed ID: 15912075
[TBL] [Abstract][Full Text] [Related]
5. Aqueous chlorhexidine 1% versus 2% for neonatal skin antisepsis: a randomised non-inferiority trial.
Sharma A; Kulkarni S; Thukral A; Sankar MJ; Agarwal R; Deorari AK; Mohapatra S; Velpandian T; Bajpai M
Arch Dis Child Fetal Neonatal Ed; 2021 Nov; 106(6):643-648. PubMed ID: 34108192
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of 2% chlorhexidine gluconate aqueous versus 2% chlorhexidine gluconate in 70% isopropyl alcohol for skin disinfection prior to percutaneous central venous catheter insertion in preterm neonates: the ARCTIC randomised-controlled feasibility trial protocol.
Clarke P; Craig JV; Wain J; Tremlett C; Linsell L; Bowler U; Juszczak E; Heath PT
BMJ Open; 2019 Feb; 9(2):e028022. PubMed ID: 30782955
[TBL] [Abstract][Full Text] [Related]
7. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates.
Garland JS; Alex CP; Uhing MR; Peterside IE; Rentz A; Harris MC
J Perinatol; 2009 Dec; 29(12):808-13. PubMed ID: 19812587
[TBL] [Abstract][Full Text] [Related]
8. Neonatal skin and chlorhexidine: a burning experience.
Kutsch J; Ottinger D
Neonatal Netw; 2014; 33(1):19-23. PubMed ID: 24413032
[TBL] [Abstract][Full Text] [Related]
9. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates.
Chapman AK; Aucott SW; Gilmore MM; Advani S; Clarke W; Milstone AM
J Perinatol; 2013 Oct; 33(10):768-71. PubMed ID: 23702618
[TBL] [Abstract][Full Text] [Related]
10. Should chlorhexidine gluconate be used in wound cleansing?
Main RC
J Wound Care; 2008 Mar; 17(3):112-4. PubMed ID: 18376652
[TBL] [Abstract][Full Text] [Related]
11. Chlorhexidine's complications.
Sivathasan N; Sivathasan N; Vijayarajan L
J Perioper Pract; 2010 Aug; 20(8):300-1. PubMed ID: 20860191
[TBL] [Abstract][Full Text] [Related]
12. Pre-operative skin antisepsis with chlorhexidine gluconate baths and wipes does not prevent postoperative surgical site infection in outpatient pediatric urologic inguinal and scrotal surgery.
Berrondo C; Ahn JJ; Shnorhavorian M
J Pediatr Urol; 2019 Dec; 15(6):652.e1-652.e7. PubMed ID: 31564588
[TBL] [Abstract][Full Text] [Related]
13. Suppression of regrowth of normal skin flora under chlorhexidine gluconate dressings applied to chlorhexidine gluconate-prepped skin.
Bashir MH; Olson LK; Walters SA
Am J Infect Control; 2012 May; 40(4):344-8. PubMed ID: 21737178
[TBL] [Abstract][Full Text] [Related]
14. 0.2% chlorhexidine acetate as skin disinfectant prevents skin lesions in extremely preterm infants: a preliminary report.
Janssen LMA; Tostmann A; Hopman J; Liem KD
Arch Dis Child Fetal Neonatal Ed; 2018 Mar; 103(2):F97-F100. PubMed ID: 28468901
[TBL] [Abstract][Full Text] [Related]
15. Chlorhexidine use in the neonatal intensive care unit: results from a national survey.
Tamma PD; Aucott SW; Milstone AM
Infect Control Hosp Epidemiol; 2010 Aug; 31(8):846-9. PubMed ID: 20586654
[TBL] [Abstract][Full Text] [Related]
16. Preadmission Application of 2% Chlorhexidine Gluconate (CHG): Enhancing Patient Compliance While Maximizing Skin Surface Concentrations.
Edmiston CE; Krepel CJ; Spencer MP; Ferraz AA; Seabrook GR; Lee CJ; Lewis BD; Brown KR; Rossi PJ; Malinowski MJ; Edmiston SE; Ferraz EM; Leaper DJ
Infect Control Hosp Epidemiol; 2016 Mar; 37(3):254-9. PubMed ID: 26708510
[TBL] [Abstract][Full Text] [Related]
17. Catheter-associated bloodstream infections in the NICU: getting to zero.
Curry S; Honeycutt M; Goins G; Gilliam C
Neonatal Netw; 2009; 28(3):151-5. PubMed ID: 19451076
[TBL] [Abstract][Full Text] [Related]
18. Skin antiseptics used prior to intravascular catheter insertion.
Adams D; Elliot TS
Br J Nurs; 2007 Mar 8-21; 16(5):278-80. PubMed ID: 17505372
[TBL] [Abstract][Full Text] [Related]
19. Chlorhexidine gluconate bathing practices and skin concentrations in intensive care unit patients.
Alserehi H; Filippell M; Emerick M; Cabunoc MK; Preas MA; Sparkes C; Johnson JK; Leekha S;
Am J Infect Control; 2018 Feb; 46(2):226-228. PubMed ID: 28993110
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Education on Chlorhexidine Use in the NICU.
Pettit JD; Sharpe EL
Neonatal Netw; 2017 Sep; 36(5):294-305. PubMed ID: 28847353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
